查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863476

核酸樣品製備市場：2025-2032年全球預測（依產品、工作流程類型、應用、最終使用者和自動化程度分類）

Nucleic Acid Sample Preparation Market by Product, Workflow Type, Application, End User, Automation - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，核酸樣品製備市場將成長至 100.2 億美元，複合年成長率為 8.99%。

關鍵市場統計數據
基準年 2024 50.3億美元
預計年份：2025年 54.7億美元
預測年份 2032 100.2億美元
複合年成長率 (%) 8.99%

了解核酸樣本製備在實現可靠的分子工作流程和操作擴充性所發揮的策略作用

核酸樣品製備生態系位於生命科學、臨床診斷和工業生物技術的交會點，是分子工作流程中不可或缺的分析前基礎。提取化學、自動化和整合儀器的進步，已使樣品製備從一項常規的實驗室任務發展成為實現高通量、高重複性和下游數據品質的關鍵策略基礎。隨著定序、基於PCR的診斷和高內涵篩檢對核酸純度和樣品通量的需求不斷成長，樣品製備階段的選擇對檢測靈敏度、週轉時間和操作效率有顯著的影響。

學術研究、臨床實驗室、法醫部門和生物製藥開發領域的相關人員正日益從可擴展性和合規性兩個角度評估樣本製備。這種轉變反映了整個產業對快速診斷製備、可重複研究和經濟高效的平台部署的普遍關注。因此，供應商和最終用戶都在投資模組化儀器平台、經過驗證的套件和標準化通訊協定，以減少變異性。由此可見，核酸樣本製備的討論並非一成不變，而是一個動態領域，其發展受到技術改進、不斷變化的監管要求和不斷擴展的應用領域的驅動，這些因素共同構成了採購、研發和臨床部署等戰略決策的背景。

自動化、化學和檢驗的工作流程的創新如何重新定義樣品製備實踐和供應商生態系統

近年來，核酸樣本製備領域發生了翻天覆地的變化。技術創新與使用者需求的不斷變化相互交融，重塑了供應商的策略和實驗室的操作流程。自動化技術已從獨立的機器人附加元件發展成為整合提取、純化和品管步驟的平台，使實驗室能夠在不相應增加人工操作時間的情況下實現規模化生產。與硬體進步同步，化學技術的進步，例如改進的結合樹脂和最佳化的裂解緩衝液，減少了抑製劑的使用，提高了產量的一致性，從而直接影響了下游檢測的性能。

另一個重要變化是針對特定工作流程的試劑套件和檢驗的通訊協定的激增，這些方案均針對檢體類型和法規環境量身定做。此趨勢的驅動力源自於臨床診斷對可重複性的需求，以及分散式檢查環境中對即插即用解決方案的需求。此外，磁珠檢測法在許多工作流程中逐漸成為標準方法，這促使人們重新評估耗材供應鏈，使用者要求試劑具有多供應商相容性和開放平台。這些變化正在建構一個更模組化和互通性的生態系統，在這個系統中，快速實施和通訊協定標準化與效能本身同等重要。

評估近期關稅對樣品製備價值鏈中儀器、試劑及製造地運作及供應鏈的影響

美國貿易政策在2025年推出的政策轉變和關稅措施，正為核酸樣本製備領域的供應商和實驗室客戶帶來微妙的營運壓力。影響專用設備、進口試劑以及自動化萃取設備某些零件的關稅，可能會增加到岸成本，並改變依賴全球供應鏈的實驗室的籌資策略。為此，許多機構正在重新評估其採購基礎，實現供應商多元化，並增加關鍵耗材的安全庫存，以降低短期價格波動的風險。

除了採購環節，關稅波動也可能加速在地化趨勢，因為製造商需要權衡集中生產和本地生產之間的利弊，以保持成本競爭力。這會影響前置作業時間、品管和法規遵循性，尤其是在本地生產需要新的驗證程序或修改試劑配方的情況下。重點，關稅的累積影響也將波及利潤微薄的合約研究和服務實驗室。這些營業單位可能會將增加的成本轉嫁給下游，或重新談判服務合約以業務永續營運。總體而言，貿易政策趨勢正在推動整個價值鏈的策略調整，其特點是供應多元化、在地化生產和重新評估庫存管理實踐。

分析產品、工作流程、應用、最終用戶和自動化細分市場的趨勢，以識別差異化的採用促進因素和供應商定位機會。

從產品、工作流程類型、應用、最終用戶和自動化等維度對市場進行分解，可以揭示供應商和買家面臨的各種機會和挑戰。產品細分涵蓋儀器、套件、試劑和服務。儀器包括自動化萃取設備、離心機和真空歧管，可滿足不同的通量和整合需求。套件包括DNA萃取試劑套件、RNA萃取試劑套件和病毒核酸萃取套件，這些試劑盒專為特定樣品基質和監管要求而設計。試劑包括結合樹脂、洗脫緩衝液、裂解緩衝液和洗滌緩衝液，這些試劑決定了純度和產量特性。服務涵蓋合約研究和客製化提取服務，為缺乏內部能力的機構提供靈活性。這些產品差異會影響採購決策、驗證時間表和供應商選擇標準。

工作流程細分進一步區分了DNA萃取、微生物萃取、質體萃取、RNA萃取和病毒核酸萃取的市場需求。每種工作流程都有方法特定的子類型，例如用於DNA和RNA提取的柱層析法、磁珠法和有機溶劑萃取方法，用於微生物提取的化學和機械裂解法，以及用於質體提取的鹼性法和SDS法，這些子類型會影響耗材兼容性、自動化程度和檢測靈敏度。應用主導的需求出現在臨床診斷、藥物發現與開發、法醫分析、基因組學研究和個人化醫療等領域，每個領域對樣品製備方案都有不同的監管、通量和品質要求。最終用戶涵蓋學術和臨床實驗室、法醫和工業實驗室、製藥公司以及生物技術公司，預算週期、認證要求和通量預期影響著他們的採用模式。最後，自動化程度（全自動、手動或半自動）決定了資本投資和人事費用節約之間的平衡，進而影響整體擁有成本的考量，並影響實驗室採用新平台的速度。

檢驗區域法規結構、採購行為和製造能力如何影響主要全球市場的採用趨勢和供應商策略

區域趨勢對核酸樣本製備領域的籌資策略、監管合規性和創新採納有顯著影響。在美洲，對臨床診斷整合、轉化研究應用和高通量自動化的強勁需求顯而易見，採購週期通常與健保報銷政策和公共衛生優先事項一致。這為檢驗的套件和整合儀器平台的推廣創造了有利環境，尤其是在可靠的技術支援和嚴格的監管文件相結合的情況下。區域內各國法規結構的差異也會影響診斷工作流程的採納時間。

歐洲、中東和非洲地區（EMEA）市場格局複雜多元，歐洲部分地區的監管協調與整個地區的市場成熟度不一。該地區的買家優先考慮供應商支援、CE標誌或區域認證解決方案，以及能夠應對跨境物流挑戰的靈活供應安排。本地語言培訓和特定語言的文檔通常會影響供應商的選擇。亞太地區的特徵是產能快速擴張、製造能力強大，以及市場接受度參差不齊，前沿學術機構與新興臨床市場並存。在這裡，成本驅動型採購與積極採用自動化和本土試劑生產並存，迫使國際供應商調整其商業策略以適應當地的價格分佈和夥伴關係模式。

透過平台互通性、檢驗的耗材、服務能力和永續性努力進行競爭差異化評估

核酸樣本製備領域的競爭取決於技術差異化、耗材產品組合的廣度以及提供端到端檢驗工作流程的能力。領先的儀器製造商透過平台間的互通性、處理能力的可擴展性以及能夠減少臨床和高通量研究客戶停機時間的服務網路來脫穎而出。套件和試劑供應商則在與領先儀器的整合便捷性、對多種檢體類型的應對力以及支援臨床和研究應用案例的檢驗資料強度方面展開競爭。包括受託研究機構(CRO) 和客製化提取實驗室在內的服務供應商，透過提供檢驗的流程和對特殊檢體類型的快速回應來開闢市場。

儀器供應商和試劑開發商之間的策略聯盟和交叉授權合約日益普遍，這加快了完整解決方案的上市速度，並縮短了實驗室檢驗時間。此外，越來越多的公司加強對應用程式支援團隊和培訓專案的投入，以降低採用門檻，尤其對於那些從手動工作流程過渡到自動化工作流程的使用者而言。永續性方面的考量，例如減少塑膠廢棄物和使用可回收耗材，正開始影響採購選擇和產品開發藍圖，為競爭定位增添了新的維度。

為供應商和實驗室管理人員提供加速採用、降低供應鏈風險以及使商業模式與客戶工作流程保持一致的實用策略

透過推行目標明確、切實可行的舉措，產業領導者可以將不斷變化的市場動態轉化為策略優勢。首先，優先考慮模組化平台設計和開放原始碼互通性，可以增加可應用場景，緩解買家對供應商鎖定的擔憂，並擴大商業性覆蓋範圍。其次，投資檢驗的端到端工作流程和完善的技術文檔，可以加快客戶採納速度並縮短價值實現時間，這對臨床實驗室客戶尤其重要。第三，實現製造地和採購管道多元化，可以降低關稅帶來的成本壓力，同時提高應對供應中斷的能力。

除了產品和供應層面，領導者還應透過彈性價格設定模式來強化其商業性提案。這些模式包括試劑租賃、按次付費模式以及符合客戶營運預算的服務包。加強區域支援網路和本地化培訓計劃可以提高不同法規環境下的採用率，而與臨床和學術機構建立有針對性的夥伴關係則可以產生高品質的檢驗數據並獲得醫療服務提供者的認可。最後，將永續性目標納入產品設計和耗材生命週期規劃，可以使供應商憑藉前瞻性的採購政策脫穎而出，並幫助組織與機構的ESG目標保持一致。

本分析背後的調查方法採用了嚴格的混合方法研究通訊協定，結合了對醫療保健專業人員的訪談、技術文獻、監管審查和交叉檢驗，以確保對該行業的深刻見解。

本分析所採用的研究途徑結合了第一手資料和第二手資料，以確保對主題研究結果進行三角檢驗。第一手資料包括對臨床實驗室營運主管、學術機構採購負責人、受託研究機構技術總監以及儀器和試劑供應商產品經理的結構化訪談。這些訪談重點在於實際應用中的挑戰、檢驗的考慮因素以及採購優先事項。第二手資料包括關於萃取化學的同行評審文獻、與臨床診斷相關的監管指導文件、記錄創新軌蹟的專利申請以及儀器供應商的技術手冊，以了解其整合能力。

定性分析的綜合分析採用了交叉檢驗流程，具體而言，是將供應商的能力和相容性聲明與獨立使用者證言和監管文件進行交叉核對。此外，也參考了近期影響貿易和關稅的公共變化，以闡明其對供應鏈的影響。在整個過程中，透過對主要受訪者資料進行匿名化處理並對關鍵聲明進行多重確認，有效控制了潛在的偏差，從而構建了一套觀點實踐經驗的可靠證據體系，為本報告中提出的戰略見解提供了有力支撐。

策略要務的整合：自動化、檢驗的耗材和可靠的採購管道共同提升了分子偵測效能。

核酸樣品製備在分子生態系中扮演核心角色，萃取化學、自動化和檢驗工作流程的改進直接影響診斷靈敏度、研究可重複性和操作效率。這一格局將繼續受到整合硬體、耗材和軟體的技術融合平台以及受區域法規、關稅環境和組織優先事項驅動的採購行為轉變的影響。能夠使其產品藍圖與客戶在檢驗時間、供應可靠性和整體擁有成本方面面臨的挑戰相契合的供應商，將更有利於把握持續的需求。

實驗室和企業負責人迫切需要平衡當前業務的連續性與對自動化、檢驗的耗材進行策略性投資，以支援未來的檢測擴展。將供應商多元化納入籌資策略、與供應商進行聯合檢驗活動以及要求提供透明的技術論證，可以減少實施阻力並提高檢測可靠性。透過共同採取這些措施，各機構可以最大限度地利用樣品製備技術的進步，並將其轉化為下游分子診斷結果的可衡量改進。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 開發一種基於磁性奈米粒子的核酸純化方法，用於液態生物檢體應用
  • 利用機器人液體處理系統實現高通量樣品製備工作流程自動化
  • 推出用於就地檢驗的基於微流體晶片的核酸萃取技術
  • 最佳化的直接PCR相容樣品製備試劑套件，省略了傳統的純化步驟
  • 用於轉錄組學的超低體積單細胞核酸分離方法的進展
  • 將人工智慧驅動的品管分析整合到樣品製備工作流程中
  • 開發環境友善核酸萃取通訊協定，減少試劑用量
  • 用於腫瘤研究的自動化FFPE組織核酸萃取套件的標準化
  • 在核酸樣品製備過程中引入數位化實驗室資訊學和LIMS整合
  • 一種能夠同時萃取DNA和RNA的多重以微珠為基礎純化平台的出現

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 核酸樣品製備市場（依產品分類）

  • 裝置
    • 自動提取裝置
    • 離心機
    • 真空歧管
  • 套件
    • DNA萃取試劑套件
    • RNA萃取試劑套件
    • 病毒核酸萃取套件
  • 試劑
    • 黏合樹脂
    • 洗脫緩衝液
    • 裂解緩衝液
    • 洗滌緩衝液
  • 服務
    • 合約研究
    • 客製化提取服務

9. 依工作流程類型分類的核酸樣品製備市場

  • DNA萃取
    • 基於列
    • 以微珠為基礎的
    • 有機萃取
  • 微生物萃取
    • 化學溶解
    • 機械溶解
  • 質體萃取
    • 鹼性溶解
    • 基於SDS
  • RNA萃取
    • 基於列
    • 以微珠為基礎的
    • 有機萃取
  • 病毒核酸萃取
    • 基於列
    • 以微珠為基礎的

第10章 依應用分類的核酸樣品製備市場

  • 臨床診斷
  • 藥物發現與開發
  • 法醫學分析
  • 基因組研究
  • 個人化醫療

第11章 核酸樣品製備市場（依最終用戶分類）

  • 學術研究機構
  • 臨床實驗室
  • 法醫科學研究所
  • 工業研究院
  • 製藥和生物技術公司

12. 核酸樣品製備市場依自動化程度分類

  • 全自動
  • 手動的
  • 半自動

13. 各地區核酸樣品製備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 核酸樣品製備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國核酸樣品製備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • Illumina, Inc.
    • Takara Bio Inc.
    • New England Biolabs, Inc.
Product Code: MRR-5C6F41F5B02F

The Nucleic Acid Sample Preparation Market is projected to grow by USD 10.02 billion at a CAGR of 8.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.03 billion
Estimated Year [2025] USD 5.47 billion
Forecast Year [2032] USD 10.02 billion
CAGR (%) 8.99%

Understanding the strategic role of nucleic acid sample preparation in enabling reliable molecular workflows and operational scalability

The nucleic acid sample preparation ecosystem sits at the intersection of life sciences, clinical diagnostics, and industrial biotechnology, serving as the essential pre-analytical backbone for molecular workflows. Advances in extraction chemistry, automation, and integrated instruments have elevated sample prep from a routine laboratory task to a strategic enabler of throughput, reproducibility, and downstream data quality. As sequencing, PCR-based diagnostics, and high-content screening continue to demand purer nucleic acids and higher sample throughput, the choices made at the sample preparation stage materially influence assay sensitivity, turnaround time, and operational efficiency.

Stakeholders across academic research, clinical labs, forensic units, and biopharma development are increasingly evaluating sample preparation through the twin lenses of scalability and compliance. This shift reflects broader industry priorities including rapid diagnostic readiness, reproducible research, and cost-effective platform deployment. Consequently, vendors and end users alike are investing in modular instrument platforms, validated kits, and standardized protocols that reduce variability. The narrative of nucleic acid sample preparation is therefore not static; it is a dynamic field driven by technological refinement, evolving regulatory expectations, and expanding application domains that together set the context for strategic decisions in procurement, R&D, and clinical deployment.

How innovations in automation, chemistry, and validated workflows are redefining sample preparation practices and vendor ecosystems

Recent years have seen transformative shifts across the nucleic acid sample preparation landscape, where technological innovation and changing user demands converge to reshape vendor strategies and laboratory practices. Automation has moved beyond single-use robotic add-ons to integrated platforms that combine extraction, purification, and quality control steps, enabling laboratories to scale without proportionate increases in hands-on time. Parallel to hardware evolution, chemistry improvements such as enhanced binding resins and optimized lysis buffers have reduced inhibitory substances and improved yield consistency, directly impacting downstream assay performance.

Another important shift is the proliferation of workflow-specific kits and validated protocols tailored to sample types and regulatory environments. This trend has been driven by the need for reproducibility in clinical diagnostics and the demand for plug-and-play solutions in decentralized testing environments. Additionally, the rise of magnetic bead-based methods as a default for many workflows has prompted a reassessment of consumable supply chains, with users seeking multi-vendor compatibility and open-platform reagents. Taken together, these changes are creating a more modular, interoperable ecosystem where rapid deployment and protocol standardization are prioritized alongside raw performance.

Assessing the operational and supply chain ramifications of recent tariff actions on instruments, reagents, and manufacturing footprints within the sample preparation value chain

Policy shifts and tariff measures introduced in 2025 within United States trade policy have introduced nuanced operational pressures for suppliers and laboratory customers involved in nucleic acid sample preparation. Tariffs that affect specialized instruments, imported reagents, and certain components used in automated extractors have the potential to increase landed costs and alter sourcing strategies for laboratories that rely on global supply chains. In response, many organizations are reassessing their procurement footprints, exploring diversified supplier panels, and increasing safety stock for critical consumables to mitigate near-term volatility.

Beyond procurement, tariff-related changes can accelerate regionalization trends as manufacturers evaluate the trade-offs between centralized production and localized manufacturing to preserve cost competitiveness. This has implications for lead times, quality control frameworks, and regulatory compliance, particularly where local production requires new validation steps or changes in reagent formulations. Importantly, the cumulative impact of tariffs extends to contract research providers and service laboratories that operate on thin margins; these entities may pass increased costs downstream or renegotiate service contracts to maintain viability. In sum, trade policy developments are prompting a strategic recalibration across the value chain, characterized by supply diversification, manufacturing localization, and revised inventory management practices.

Parsing product, workflow, application, end user, and automation segment dynamics to reveal differentiated adoption drivers and vendor positioning opportunities

Deconstructing the market along product, workflow type, application, end user, and automation axes reveals nuanced opportunities and constraints for vendors and buyers alike. Product segmentation spans instruments, kits, reagents, and services, where instruments encompass automated extractors, centrifuges, and vacuum manifolds that address different throughput and integration needs; kits include DNA extraction kits, RNA extraction kits, and viral nucleic acid extraction kits designed for specific sample matrices and regulatory demands; reagents consist of binding resins, elution buffers, lysis buffers, and wash buffers that determine purity and yield characteristics; and services cover contract research and custom extraction services that provide flexibility for organizations without in-house capacity. These product distinctions inform purchasing decisions, validation timelines, and vendor selection criteria.

Workflow segmentation further differentiates market needs across DNA extraction, microbial extraction, plasmid extraction, RNA extraction, and viral nucleic acid extraction. Each workflow contains method-specific subtypes-such as column-based, magnetic bead-based, and organic extraction for DNA and RNA; chemical lysis and mechanical lysis for microbial extraction; and alkaline lysis or SDS-based methods for plasmid extraction-that influence consumable compatibility, automation potential, and assay sensitivity. Application-driven demand emerges across clinical diagnostics, drug discovery and development, forensic analysis, genomic research, and personalized medicine, each placing distinct regulatory, throughput, and quality requirements on sample prep choices. End users range from academic research laboratories and clinical laboratories to forensic and industrial labs, as well as pharmaceutical and biotechnology companies, with adoption patterns shaped by budget cycles, accreditation needs, and throughput expectations. Finally, automation tiers-fully automated, manual, and semi-automated-define the balance between capital expenditure and labor savings, shaping total cost of ownership considerations and influencing the pace at which labs adopt new platforms.

Examining how regional regulatory frameworks, procurement behaviors, and manufacturing capacity shape adoption and vendor strategy across major global markets

Regional dynamics significantly influence procurement strategies, regulatory compliance, and innovation adoption within the nucleic acid sample preparation space. The Americas demonstrate a strong emphasis on clinical diagnostics integration, translational research applications, and an appetite for high-throughput automation, with procurement cycles often tied to reimbursement policies and public health priorities. This creates an environment where validated kits and integrated instrument platforms gain traction, especially when coupled with reliable technical support and rigorous regulatory documentation. Comparative regulatory frameworks across countries within the region also affect time-to-deployment for diagnostic workflows.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in parts of Europe coexists with variable market maturity across the Middle East and Africa. Buyers in this region prioritize vendor support, CE-marked or regionally certified solutions, and flexible supply arrangements that account for cross-border logistics challenges. Localized training and language-specific documentation frequently influence vendor selection. The Asia-Pacific region is characterized by rapid capacity expansion, strong manufacturing capabilities, and a mixed adoption curve where cutting-edge academic centers coexist with emerging clinical markets. Here, cost-sensitive procurement coexists with aggressive adoption of automation and domestic reagent production, prompting international vendors to adapt commercial strategies to local price points and partnership models.

Evaluating competitive differentiation through platform interoperability, validated consumables, service capabilities, and sustainability commitments

Competitive dynamics in nucleic acid sample preparation are influenced by a combination of technological differentiation, breadth of consumable portfolios, and the ability to provide end-to-end validated workflows. Leading instrument manufacturers differentiate through platform interoperability, throughput scaling, and service networks that reduce downtime for clinical and high-throughput research customers. Kit and reagent suppliers compete on ease of integration with popular instruments, robustness across sample types, and the strength of validation data supporting clinical or research use cases. Service providers, including contract research organizations and custom extraction labs, carve niches by offering validated pipelines and rapid turnaround times for specialized sample types.

Strategic partnerships and cross-licensing arrangements between instrument vendors and reagent developers are frequent, enabling faster market entry for complete solutions and helping laboratories shorten validation timelines. Additionally, an increasing number of companies are investing in application support teams and training programs to reduce adoption friction, particularly for buyers transitioning from manual to automated workflows. Sustainability considerations, such as reduced plastic waste and recyclable consumables, are beginning to influence procurement choices and product development roadmaps, adding an additional dimension to competitive positioning.

Actionable strategies for vendors and laboratory leaders to accelerate adoption, de-risk supply chains, and align commercial models with customer workflows

Industry leaders can convert shifting market dynamics into strategic advantage by pursuing a set of focused, actionable initiatives. First, prioritizing modular platform design and open-source interoperability increases addressable use cases and reduces buyer reluctance around vendor lock-in, thereby expanding commercial reach. Second, investing in validated end-to-end workflows and robust technical documentation accelerates customer onboarding and shortens time-to-value, which is particularly important for clinical laboratory customers. Third, diversifying manufacturing and sourcing footprints mitigates exposure to tariff-driven cost pressures while improving resilience against disruption.

Beyond product and supply considerations, leaders should enhance commercial propositions through flexible pricing models, including reagent leasing, pay-per-test arrangements, and bundled service offerings that align with customers' operational budgets. Strengthening regional support networks and localized training initiatives will improve adoption rates in diverse regulatory environments, while targeted partnerships with clinical and academic centers can generate high-quality validation data and practitioner advocacy. Finally, embedding sustainability targets into product design and consumable lifecycle planning can differentiate vendors with forward-looking procurement mandates and help organizations align with institutional ESG objectives.

A rigorous mixed-methods research protocol combining practitioner interviews, technical literature, regulatory review, and cross-validation to ensure robust industry insights

The research approach underpinning this analysis combined primary and secondary methods to ensure triangulation and validation of thematic findings. Primary inputs included structured interviews with operational leaders in clinical laboratories, procurement managers at academic institutions, technical directors at contract research providers, and product managers at instrument and reagent suppliers. These engagements focused on real-world adoption challenges, validation considerations, and procurement priorities. Secondary inputs comprised peer-reviewed literature on extraction chemistries, regulatory guidance documents relevant to clinical diagnostics, patent filings that highlight innovation trajectories, and technical manuals from instrument vendors to understand integration capabilities.

Qualitative synthesis was complemented by cross-validation steps, where vendor claims about throughput and compatibility were contrasted against independent user testimony and regulatory documentation. Attention was paid to recent public policy changes affecting trade and tariffs to contextualize supply chain implications. Throughout the process, potential biases were managed by anonymizing primary respondent data and seeking multiple confirmations for critical assertions, resulting in a robust, practitioner-focused body of evidence that supports the strategic insights presented in this report.

Synthesizing strategic imperatives where automation, validated consumables, and resilient sourcing converge to enhance molecular assay performance

Nucleic acid sample preparation occupies a pivotal role in the molecular ecosystem, where improvements in extraction chemistry, automation, and validated workflows directly influence diagnostic sensitivity, research reproducibility, and operational throughput. The landscape will continue to be shaped by technological convergence-platforms that integrate hardware, consumables, and software-alongside shifting procurement behaviors driven by regional regulations, tariff environments, and institutional priorities. Vendors that align product roadmaps with customer pain points such as validation time, supply reliability, and total cost of ownership will be best positioned to capture durable demand.

For laboratories and corporate buyers, the imperative is to balance near-term operational resilience with strategic investments in automation and validated consumables that support future assay expansion. Building supplier diversity into sourcing strategies, engaging in collaborative validation exercises with vendors, and demanding transparent technical evidence will reduce deployment friction and enhance assay reliability. Taken together, these steps will enable organizations to harness the full potential of advances in sample preparation and translate them into measurable improvements in downstream molecular outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of magnetic nanoparticle-based nucleic acid purification for liquid biopsy applications
  • 5.2. Automation of high-throughput sample preparation workflows with robotic liquid handlers
  • 5.3. Implementation of microfluidic chip-based nucleic acid extraction for point-of-care testing
  • 5.4. Optimization of direct-to-PCR sample preparation kits eliminating traditional purification steps
  • 5.5. Advancements in ultra low-input single-cell nucleic acid isolation methods for transcriptomics
  • 5.6. Integration of artificial intelligence-driven quality control analytics in sample prep workflows
  • 5.7. Development of environmentally friendly and reagent-reduced nucleic acid extraction protocols
  • 5.8. Standardization of automated FFPE tissue nucleic acid co-extraction kits for oncology research
  • 5.9. Adoption of digital lab informatics and LIMS integration in nucleic acid sample preparation processes
  • 5.10. Emergence of multiplexed bead-based purification platforms for simultaneous DNA and RNA extraction

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Sample Preparation Market, by Product

  • 8.1. Instruments
    • 8.1.1. Automated Extractors
    • 8.1.2. Centrifuges
    • 8.1.3. Vacuum Manifolds
  • 8.2. Kits
    • 8.2.1. Dna Extraction Kits
    • 8.2.2. Rna Extraction Kits
    • 8.2.3. Viral Nucleic Acid Extraction Kits
  • 8.3. Reagents
    • 8.3.1. Binding Resins
    • 8.3.2. Elution Buffers
    • 8.3.3. Lysis Buffers
    • 8.3.4. Wash Buffers
  • 8.4. Services
    • 8.4.1. Contract Research
    • 8.4.2. Custom Extraction Services

9. Nucleic Acid Sample Preparation Market, by Workflow Type

  • 9.1. Dna Extraction
    • 9.1.1. Column Based
    • 9.1.2. Magnetic Bead Based
    • 9.1.3. Organic Extraction
  • 9.2. Microbial Extraction
    • 9.2.1. Chemical Lysis
    • 9.2.2. Mechanical Lysis
  • 9.3. Plasmid Extraction
    • 9.3.1. Alkaline Lysis
    • 9.3.2. Sds Based
  • 9.4. Rna Extraction
    • 9.4.1. Column Based
    • 9.4.2. Magnetic Bead Based
    • 9.4.3. Organic Extraction
  • 9.5. Viral Nucleic Acid Extraction
    • 9.5.1. Column Based
    • 9.5.2. Magnetic Bead Based

10. Nucleic Acid Sample Preparation Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Drug Discovery And Development
  • 10.3. Forensic Analysis
  • 10.4. Genomic Research
  • 10.5. Personalized Medicine

11. Nucleic Acid Sample Preparation Market, by End User

  • 11.1. Academic Research Laboratories
  • 11.2. Clinical Laboratories
  • 11.3. Forensic Laboratories
  • 11.4. Industrial Laboratories
  • 11.5. Pharmaceutical And Biotechnology Companies

12. Nucleic Acid Sample Preparation Market, by Automation

  • 12.1. Fully Automated
  • 12.2. Manual
  • 12.3. Semi Automated

13. Nucleic Acid Sample Preparation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nucleic Acid Sample Preparation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nucleic Acid Sample Preparation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. QIAGEN N.V.
    • 16.3.3. F. Hoffmann-La Roche Ltd.
    • 16.3.4. Merck KGaA
    • 16.3.5. Bio-Rad Laboratories, Inc.
    • 16.3.6. Promega Corporation
    • 16.3.7. Agilent Technologies, Inc.
    • 16.3.8. Illumina, Inc.
    • 16.3.9. Takara Bio Inc.
    • 16.3.10. New England Biolabs, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NUCLEIC ACID SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET